Evidence map›Paper›PMID 42069798›Full record

ArticleActa neuropathologica2026

Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.

John L Robinson, Helen Cai, Nicholas J Loh, Omar Vazquez, Zahra Khodakaramimaghsoud, EunRan Suh, Vivianna M Van Deerlin, Paul A Yushkevich, Dawn Mechanic-Hamilton, Sharon X Xie and 5 more

Abstract read
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

John L RobinsonCenter for Neurodegenerative Disease Research (CNDR), Department of Pathology and Laboratory Medicine, Institute On Aging, University of Pennsylvania Perelman School of Medicine, Maloney Building, 3rd Floor, Philadelphia, PA, 19104, USA.
Helen CaiCenter for Neurodegenerative Disease Research (CNDR), Department of Pathology and Laboratory Medicine, Institute On Aging, University of Pennsylvania Perelman School of Medicine, Maloney Building, 3rd Floor, Philadelphia, PA, 19104, USA.
Nicholas J LohCenter for Neurodegenerative Disease Research (CNDR), Department of Pathology and Laboratory Medicine, Institute On Aging, University of Pennsylvania Perelman School of Medicine, Maloney Building, 3rd Floor, Philadelphia, PA, 19104, USA.
Omar VazquezDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Zahra KhodakaramimaghsoudDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
EunRan SuhCenter for Neurodegenerative Disease Research (CNDR), Department of Pathology and Laboratory Medicine, Institute On Aging, University of Pennsylvania Perelman School of Medicine, Maloney Building, 3rd Floor, Philadelphia, PA, 19104, USA.
Vivianna M Van DeerlinCenter for Neurodegenerative Disease Research (CNDR), Department of Pathology and Laboratory Medicine, Institute On Aging, University of Pennsylvania Perelman School of Medicine, Maloney Building, 3rd Floor, Philadelphia, PA, 19104, USA.
Paul A YushkevichDepartment of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Dawn Mechanic-HamiltonDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Sharon X XieDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.
Daniel T OhmDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
David A WolkDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
David J IrwinDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Jeffrey S PhillipsDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Edward B LeeCenter for Neurodegenerative Disease Research (CNDR), Department of Pathology and Laboratory Medicine, Institute On Aging, University of Pennsylvania Perelman School of Medicine, Maloney Building, 3rd Floor, Philadelphia, PA, 19104, USA. edward.lee@pennmedicine.upenn.edu.

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Corey T McMillan · 2021 to 2026
$24.8M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David John Irwin, Corey T McMillan · 2020 to 2026
$18.8M
Project IV: In Vivo Dissection of Genetic Modifiers on Different Stages of SynucleinopathyP01AG084497 · NIA · UNIVERSITY OF PENNSYLVANIA · PI ALICE S CHEN-PLOTKIN · 2024 to 2026
$15.2M
Spreading Tau Pathology in Non-Amnestic Alzheimer's DiseaseR01AG054519 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey S Phillips · 2018 to 2026
$7.4M
Loss of VCP Function in Frontotemporal Lobar DegenerationRF1AG065341 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, EDWARD BYUNG-HA · 2022 to 2022
$2.4M
NIA NIH HHS P01 AG066597NIA NIH HHS P01 AG084497NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG054519NIA NIH HHS RF1 AG065341NIH HHS P30AG072979, P01AG066597, P01AG084497, RF1AG065341, ROIAG054519
6 · The paper itself

Abstract

Neurofibrillary tangles in Alzheimer's disease (AD) stereotypically spread from the medial temporal lobe to association areas and then to idiotypic areas (i.e., primary motor, somatosensory, auditory, and visual). Previous studies have reported variable and clinically relevant tangle densities across the hippocampus and association cortices, but the idiotypic tangle burden is understudied. In this study, we measured tangle density using immunohistochemistry in three idiotypic cortices (primary motor, somatosensory, and visual), three association cortices (middle frontal, superior temporal, and inferior parietal), and two hippocampal sectors (CA1 and subiculum) in 144 cases with a high level of AD neuropathologic change. Clinical diagnoses included late-onset AD (LOAD, n = 50), early-onset AD (EOAD, n = 21), behavioral variant frontotemporal dementia (bvFTD, n = 19), corticobasal syndrome (CBS, n = 18), logopenic primary progressive aphasia (lvPPA, n = 21), and posterior cortical atrophy (PCA, n = 15). We algorithmically assigned cases outside the interquartile ranges of mean tangle ratios of association:hippocampal, idiotypic:association, and idiotypic:hippocampal to mutually exclusive subtypes: idiotypic-susceptible, associative-predominant, limbic-predominant, or typical Braak (for all remaining cases). Regional tangle burdens differentiated subtypes, while female sex, younger ages, and longer disease durations also influenced tangle severity. Compared to typical Braak cases, idiotypic-susceptible and associative-predominant cases exhibited shorter disease duration and younger age at death while limbic-predominant cases were older. The MAPT H1H1 haplotype also differed by subtype, being most prevalent in limbic-predominant and least common in idiotypic-susceptible and associative-predominant subtypes. Clinically, the idiotypic-susceptible subtype associated with CBS (56%), the associative-predominant subtype with bvFTD (53%), and the limbic-predominant subtype with LOAD (14%). The typical Braak subtype characterized 74-76% of amnestic AD cases and 32-53% of non-amnestic AD cases. Moreover, k-means clustering corroborated four clusters including the idiotypic-susceptible and associative-predominant patterns. Our results confirm previously described tau subtypes and describe an idiotypic-predominant subtype with clinical relevance and distinct demographic and genetic characteristics in AD.

Indexed as

Alzheimer DiseaseBrainCerebral CortexNeurofibrillary TanglesAgedAged, 80 and overFemaleHumansMaleMiddle Agedtau Proteinstau ProteinsAlzheimer’s diseaseNeurofibrillary tangleNon-amnesticSubtypeTau

Identifiers

PMID42069798
PMCPMC13135531

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.